Sandra B. Munro

Sandra B. Munro joined IHME as a Publications Officer in the Local Burden of Disease in January of 2019. She has worked for more than 20 years in molecular biology and microbiology, including in collaboration with the U.S. Army and Air Force to develop detection technologies for biothreat agents, and as a Research Scientist at the University of Washington to develop clinical diagnostics for infectious diseases. She completed her PhD in Molecular Biology at McGill University, Montreal.

Researcher Marina Soloviecika holds tubes of a deadly strain of E.coli isolated during an outbreak in Riga, Latvia on June 9, 2011. Many other types of bacteria live safely in or on the human body. The image shows a few testtubes filled with liquid that has a very distinctive purple “lid.” The researcher can be seen blurred out in the background. REUTERS/Ints Kalnins
Food

What are Microbiomes and Probiotics?

by Sandra B. Munro, Andy McShea

The first in a series on bacteria in the gut and their potential for improving health and addressing malnutrition

Technician doing eye exam during azithromycin mass drug administration training exercise near Ouagadougou, Burkina Faso.
Aging

Mass Drug Administration of Azithromycin: Promise or Peril?

by Sandra B. Munro

Mass drug administration of azithromycin saves children’s lives—is that enough to justify risk of antibiotic resistance?